Collins Helen Louise Insider Trades & Stock Holdings

CHIEF MEDICAL OFFICER · Enliven Therapeutics, Inc. · Latest filing Sep 17, 2026

Collins Helen Louise, CHIEF MEDICAL OFFICER at Enliven Therapeutics, Inc. has 1 Form 4 trade on file since Sep 17, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($251.75K), net -$251.75K. Latest filing: disposed of 5K shares of $ELVN on Sep 17, 2026 at $50.35.

Trades on file

1

Open-market bought

$0

Open-market sold

$251.75K

Net open-market

-$251.75K

Latest filing

Sep 17, 2026

All insider trades by Collins Helen Louise

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 17, 2026	$ELVN	Sell (Open-market sale) 10b5-1	5K	$50.35	$251.75K			-10.1%			CHIEF MEDICAL OFFICER		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Collins Helen Louise traded

• $ELVN

Frequently asked questions

Has Collins Helen Louise been buying or selling stock?

Collins Helen Louise has 0 open-market purchases and 1 open-market sale on file, net -$251.75K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Collins Helen Louise's latest insider trade?

disposed of 5K shares of $ELVN on Sep 17, 2026 at $50.35.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.